LV10918B - Method of use of azithromycin - Google Patents
Method of use of azithromycin Download PDFInfo
- Publication number
- LV10918B LV10918B LVP-95-115A LV950115A LV10918B LV 10918 B LV10918 B LV 10918B LV 950115 A LV950115 A LV 950115A LV 10918 B LV10918 B LV 10918B
- Authority
- LV
- Latvia
- Prior art keywords
- azithromycin
- dosage form
- food
- oral
- suspension
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Claims (16)
- LV 10918 Izgudrojuma formula 1. Azitromicīna pielietojums tāda ārstniecības līdzekja iegūšanai, kas izmantojams bakteriālo infekciju ārstēšanai zīdītājiem, kura perorālās formas iedarbību nevēlami neietekmē iepriekš uzņemtā barība.
- 2. Pielietojums pēc 1. punkta, kur minētais zīdītājs ir cilvēks.
- 3. Pielietojums pēc 2. punkta, kur minētai formai attiecība starp plazmā nonākušās vielas daudzumu paēdušam dzīvniekam pret to pašu nepaēdušam dzīvniekam ir vismaz 0.80 ar zemāko 90% ticamības ffmeni vismaz 0.75.
- 4. Pielietojums pēc 2. punkta, kur minētā forma ir tablete.
- 5. Pielietojums pēc 2. punkta, kur minētā forma ir pulveris vai perorāli lietojama suspensija.
- 6. Pielietojums pēc 5. punkta, kur minētā forma ir suspensija, kas pagatavota no minētā pulvera.
- 7. Pielietojums pēc 2. punkta, kur minētā forma ir vienreizējas izmantošanas iesaiņojumā.
- 8. Pielietojums pēc 7. punkta, kur minētā forma ir suspensija, kas pagatavota no minētā vienreizējās izmantošanas iesaiņojuma. 1
- 9. Iesaiņots ārstniecības līdzeklis, kas piemērots pārdošanai un sastāv no konteinera, tajā ievietotas azitromicīna perorālās formas, kuras iedarbību nevēlami neietekmē uzņemtā barība, kā arī minētajam iesaiņotajam ārstniecības līdzeklim pievienota apraksta, kurā, cita starpā, norādīts, vai perorālo formu var lietot ar ēdienu vai bez tā.
- 10. Iesaiņots ārstniecības līdzeklis pēc 9. punkta, kur minētā forma ir tablete.
- 11. Iesaiņots ārstniecības līdzeklis pēc 9. punkta, kur minētā forma ir pulveris perorāli lietojamas suspensijas pagatavošanai.
- 12. Iesaiņots ārstniecības līdzeklis pēc 11. punkta, kur minētā forma ir suspensija, kas pagatavota no minētā pulvera.
- 13. Iesaiņots ārstniecības līdzeklis pēc 9. punkta, kur minētā forma ir vienreizējas lietošanas iesaiņojumā.
- 14. Iesaiņots ārstniecības līdzeklis pēc 13. punkta, kur minētā forma ir suspensija, kas pagatavota no minētā vienreizējās lietošanas iesaiņojuma.
- 15. Terapeitiski aktīvas azitromicīna devas pielietojums tādas farmaceitiskās formas pagatavošanai, kuru nevēlami neietekmē uzņemtā barība, un kas paredzēta mikrobiālas infekcijas ārstēšanai tādam slimniekam, kas ir uzņēmis barību.
- 16. Azitromicīna pielietojums tādas farmaceitiskās formas pagatavošanai, kuru nevēlami neietekmē uzņemtā barība, pie kam minētai formai pievienots apraksts, kur, cita starpā, norādīts, vai minēto formu var lietot ar ēdienu, vai bez tā. 2
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/235,069 US5605889A (en) | 1994-04-29 | 1994-04-29 | Method of administering azithromycin |
Publications (2)
Publication Number | Publication Date |
---|---|
LV10918A LV10918A (lv) | 1995-12-20 |
LV10918B true LV10918B (en) | 1996-06-20 |
Family
ID=22883977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LVP-95-115A LV10918B (en) | 1994-04-29 | 1995-04-28 | Method of use of azithromycin |
Country Status (31)
Country | Link |
---|---|
US (2) | US5605889A (lv) |
EP (1) | EP0679400B1 (lv) |
JP (3) | JPH07300420A (lv) |
KR (1) | KR100354310B1 (lv) |
CN (1) | CN1088362C (lv) |
AP (1) | AP566A (lv) |
AT (1) | ATE183395T1 (lv) |
AU (1) | AU709328B2 (lv) |
CA (1) | CA2148071C (lv) |
CO (1) | CO4560547A1 (lv) |
DE (1) | DE69511451T2 (lv) |
DK (1) | DK0679400T3 (lv) |
DZ (1) | DZ1877A1 (lv) |
ES (1) | ES2136247T3 (lv) |
FI (1) | FI952060A (lv) |
GR (1) | GR3031290T3 (lv) |
HU (1) | HUT75244A (lv) |
IL (1) | IL113437A (lv) |
LV (1) | LV10918B (lv) |
MA (1) | MA23533A1 (lv) |
NO (1) | NO314386B1 (lv) |
NZ (1) | NZ548384A (lv) |
OA (1) | OA10151A (lv) |
RU (1) | RU2128998C1 (lv) |
SI (1) | SI0679400T1 (lv) |
TN (1) | TNSN95046A1 (lv) |
TW (1) | TW499311B (lv) |
UA (1) | UA34464C2 (lv) |
UY (1) | UY23935A1 (lv) |
YU (1) | YU49483B (lv) |
ZA (1) | ZA953439B (lv) |
Families Citing this family (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RO114740B1 (ro) † | 1994-05-06 | 1999-07-30 | Pfizer | Compozitie cu eliberare controlata, procedeu de obtinere a acesteia si metoda de tratament |
ES2079327B1 (es) * | 1994-12-13 | 1996-08-01 | Lilly Sa | Formulaciones farmaceuticas de cefaclor. |
ATE216576T1 (de) * | 1995-02-08 | 2002-05-15 | Yamanouchi Europ Bv | Vehrfahren zur herstellung von beta-lactam antibiotikum enthaltenden oralen dosisformen |
US20060003447A1 (en) * | 2003-12-30 | 2006-01-05 | Richard Fike | Dry powder cells and cell culture reagents and methods of production thereof |
US6383810B2 (en) * | 1997-02-14 | 2002-05-07 | Invitrogen Corporation | Dry powder cells and cell culture reagents and methods of production thereof |
US20030212123A1 (en) * | 1997-05-05 | 2003-11-13 | Pfizer Inc. | COX-2 selective carprofen for treating pain and inflammation in dogs |
US6146655A (en) * | 1997-08-29 | 2000-11-14 | Softy-Flex Inc. | Flexible intra-oral bandage and drug delivery system |
US6129932A (en) * | 1997-09-05 | 2000-10-10 | Merck & Co., Inc. | Compositions for inhibiting platelet aggregation |
US6861411B1 (en) * | 1997-12-02 | 2005-03-01 | Pfizer, Inc. | Method of treating eye infections with azithromycin |
US5955107A (en) * | 1997-12-12 | 1999-09-21 | Fmc Corporation | Pharmaceutical suspension tablet compositions |
US5916594A (en) * | 1997-12-22 | 1999-06-29 | Schering Corporation | Process of making solid ribavirin dosage forms |
CA2300452C (en) * | 1997-12-22 | 2000-11-28 | Schering Corporation | Orally administrable solid ribavirin dosage forms and process for making them |
US5914128A (en) * | 1997-12-22 | 1999-06-22 | Schering Corporation | Orally administrable solid dosage form |
US6239112B1 (en) * | 1998-07-09 | 2001-05-29 | Merial, Inc. | Water miscible macrolide solutions |
FR2793690B1 (fr) * | 1999-03-30 | 2003-01-03 | Cll Pharma | Formulations pharmaceutiques en macrolides seuls ou associes a d'autres principes actifs et leur utilisation en therapeutique |
US6239113B1 (en) | 1999-03-31 | 2001-05-29 | Insite Vision, Incorporated | Topical treatment or prevention of ocular infections |
US7056893B2 (en) * | 1999-03-31 | 2006-06-06 | Insite Vision, Inc. | Topical treatment for prevention of ocular infections |
EP1611881A1 (en) * | 1999-03-31 | 2006-01-04 | Janssen Pharmaceutica N.V. | Pregelatinized starch in a controlled release formulation |
IL141438A0 (en) * | 2000-02-23 | 2002-03-10 | Pfizer Prod Inc | Method of increasing the bioavailability and tissue penetration of azithromycin |
ATE320441T1 (de) * | 2000-07-25 | 2006-04-15 | Silanes Sa De Cv Lab | Einstufiges verfahren zur herstellung von 7,16- |
DE60114028T2 (de) | 2000-08-23 | 2006-07-13 | Wockhardt Ltd. | Verfahren zur herstellung von wasserfreiem azithromycin |
AU3240602A (en) * | 2000-11-06 | 2002-05-15 | Invitrogen Corp | Dry powder cells and cell culture reagents and methods of production thereof |
EP1344527B1 (en) * | 2000-11-15 | 2009-09-09 | Masao Sugamata | Macrolide antibiotics for endometriosis or uterine myoma |
HRP20010301A2 (en) * | 2001-04-27 | 2001-12-31 | Pliva D D | New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases |
EP1671979B1 (en) | 2001-05-22 | 2008-08-13 | Pfizer Products Inc. | New Cristal Form of Azithromycin |
NZ529118A (en) * | 2001-05-22 | 2005-10-28 | Pfizer Prod Inc | Crystal forms of azithromycin |
EA200400214A1 (ru) * | 2001-08-21 | 2004-06-24 | Пфайзер Продактс Инк. | Азитромицин в виде разовой дозы |
GB0123400D0 (en) | 2001-09-28 | 2001-11-21 | Novartis Ag | Organic compounds |
AU2006218279B2 (en) * | 2001-09-28 | 2009-12-10 | Novartis Ag | Pharmaceutical compositions comprising colloidal silicon dioxide |
EP1541134A3 (en) * | 2001-10-18 | 2007-06-06 | Teva Pharmaceutical Industries Limited | Stabilized azithromycin compositions |
US20080149521A9 (en) * | 2001-10-18 | 2008-06-26 | Michael Pesachovich | Methods of stabilizing azithromycin |
US20040226852A1 (en) * | 2003-02-19 | 2004-11-18 | Michael Pesachovich | Method of stabilizing azithromycin |
DE60232005D1 (de) * | 2001-10-18 | 2009-05-28 | Teva Pharma | Stabilisierte azithromycin-zusammensetzungen |
NZ532707A (en) * | 2001-12-21 | 2006-07-28 | Pfizer Prod Inc | Directly compressible formulations of azithromycin |
IL161259A0 (en) * | 2001-12-21 | 2004-09-27 | Pfizer Prod Inc | Methods for wet granulating azithromycin |
EP1476191A2 (en) * | 2002-01-16 | 2004-11-17 | Pepgen Corporation | Oral administration of interferon-tau |
NZ534234A (en) * | 2002-02-01 | 2007-05-31 | Pfizer Prod Inc | Dry granulated formulations of non-dihydrate form of azithromycin |
EP1490031A1 (en) * | 2002-03-07 | 2004-12-29 | Vectura Limited | Fast melt multiparticulate formulations for oral delivery |
US7101576B2 (en) * | 2002-04-12 | 2006-09-05 | Elan Pharma International Limited | Nanoparticulate megestrol formulations |
US20100226989A1 (en) * | 2002-04-12 | 2010-09-09 | Elan Pharma International, Limited | Nanoparticulate megestrol formulations |
US9101540B2 (en) | 2002-04-12 | 2015-08-11 | Alkermes Pharma Ireland Limited | Nanoparticulate megestrol formulations |
US20040105889A1 (en) * | 2002-12-03 | 2004-06-03 | Elan Pharma International Limited | Low viscosity liquid dosage forms |
GB0209265D0 (en) | 2002-04-23 | 2002-06-05 | Novartis Ag | Organic compounds |
BG748Y1 (bg) * | 2002-07-02 | 2005-06-30 | "BALKANFARMA-RAZGRAD" AD A{ô{òM{}ö{ }{GC}{D A{DAAAAAAAAAAAAAAAAAAAAAAAAAA | ЛЕКАРСТВЕНАБФОРМАБББББББББББББББББББББББББББББББББФЕДЙГБФЕХгЦдв@ЖЦЩФ@@@@@@@@@@@ |
CA2524827A1 (en) * | 2003-05-06 | 2004-11-25 | Nirmal Mulye | Controlled release formulation of erythromycin derivatives |
US20050013835A1 (en) * | 2003-07-15 | 2005-01-20 | Pfizer Inc. | Stable non-dihydrate azithromycin oral suspensions |
EP1648473B1 (en) * | 2003-07-24 | 2009-01-28 | PLIVA HRVATSKA d.o.o. | Single dose fast dissolving azithromycin |
TWI366442B (en) | 2003-07-30 | 2012-06-21 | Novartis Ag | Palatable ductile chewable veterinary composition |
US20050089502A1 (en) * | 2003-08-21 | 2005-04-28 | Todd Schansberg | Effervescent delivery system |
WO2005053639A2 (en) * | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Controlled release multiparticulates formed with dissolution enhancers |
US6984403B2 (en) * | 2003-12-04 | 2006-01-10 | Pfizer Inc. | Azithromycin dosage forms with reduced side effects |
CA2547597A1 (en) * | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Multiparticulate compositions with improved stability |
WO2005053652A1 (en) | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride |
EP1689368B1 (en) * | 2003-12-04 | 2016-09-28 | Bend Research, Inc | Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions |
MXPA06005913A (es) * | 2003-12-04 | 2006-06-27 | Pfizer Prod Inc | Formas de dosificacion de multiparticulas de azitromicina por procedimientos basados en liquidos. |
CN1889931A (zh) * | 2003-12-04 | 2007-01-03 | 辉瑞产品公司 | 利用挤压器制备优选含泊洛沙姆和甘油酯的多重粒子阿奇霉素组合物的喷雾-冻凝方法 |
CN1889932A (zh) * | 2003-12-04 | 2007-01-03 | 辉瑞产品公司 | 制备药用多颗粒的方法 |
AU2004216676B2 (en) * | 2003-12-04 | 2011-06-16 | Pfizer Products Inc. | Azithromycin dosage forms with reduced side effects |
US20050131079A1 (en) * | 2003-12-10 | 2005-06-16 | Pujara Chetan P. | Cefdinir oral suspension |
WO2005067500A2 (en) * | 2003-12-30 | 2005-07-28 | 3M Innovative Properties Company | Enhancement of immune responses |
US20060116336A1 (en) * | 2004-03-17 | 2006-06-01 | American Pharmaceutical Partners, Inc. | Lyophilized azithromycin formulation |
US7468428B2 (en) * | 2004-03-17 | 2008-12-23 | App Pharmaceuticals, Llc | Lyophilized azithromycin formulation |
JP4713104B2 (ja) * | 2004-08-04 | 2011-06-29 | ファイザー株式会社 | アジスロマイシン類を有効成分とする苦味が抑制された安定な組成物 |
US20060046970A1 (en) * | 2004-08-31 | 2006-03-02 | Insite Vision Incorporated | Topical otic compositions and methods of topical treatment of prevention of otic infections |
US20060182806A1 (en) * | 2004-11-08 | 2006-08-17 | Mintong Guo | Extended-release propranolol composition |
DE05815688T1 (de) * | 2005-01-27 | 2008-06-26 | Alembic Ltd. | Levetiracetam-formulierung mit verlängerter freisetzung |
US20060198895A1 (en) * | 2005-03-07 | 2006-09-07 | Kotliar Eleonora M | Azithromycin powder for oral suspension compositions |
AU2005328689A1 (en) * | 2005-03-07 | 2006-09-14 | Teva Pharmaceutical Industries Ltd. | Azithromycin powder for oral suspension compositions |
EP2422783B1 (en) | 2005-05-26 | 2015-04-08 | Sumitomo Dainippon Pharma Co., Ltd. | Pharmaceutical Composition |
KR101465803B1 (ko) * | 2005-08-10 | 2014-11-26 | 시오노기세이야쿠가부시키가이샤 | 구강내 붕괴 정제 |
US20070191271A1 (en) * | 2006-02-10 | 2007-08-16 | Dow Pharmaceutical Sciences | Method for stabilizing polypeptides lacking methionine |
US8187659B2 (en) | 2006-05-02 | 2012-05-29 | Jerry Robertson Real Estate Llc | Solid medicament dosage form consumption aid |
US20080014264A1 (en) * | 2006-07-13 | 2008-01-17 | Ucb, S.A. | Novel pharmaceutical compositions comprising levetiracetam |
US8124123B2 (en) * | 2007-09-05 | 2012-02-28 | Dow Pharmaceutical Sciences, Inc. | Controlled release azithromycin solid dosages forms |
TWI478712B (zh) | 2008-09-30 | 2015-04-01 | Astellas Pharma Inc | 釋控性醫藥組成物 |
WO2011122524A1 (ja) | 2010-03-29 | 2011-10-06 | アステラス製薬株式会社 | 放出制御医薬組成物 |
WO2013088274A1 (en) | 2011-12-14 | 2013-06-20 | Wockhardt Limited | Anhydrous amorphous azithromycin composition free of azithromycin dihydrate |
DE112013000869T5 (de) | 2012-02-06 | 2014-10-16 | Merial Ltd. | Orale parasitizide Veterinärzusammensetzungen umfassend systemisch wirkende Wirkstoffe, Verfahren und Verwendun davon |
CN104168895B (zh) | 2012-02-28 | 2020-02-21 | 首尔制药株式会社 | 包含西地那非作为活性成分的掩蔽苦味的高含量快速溶解膜 |
RU2498805C1 (ru) * | 2012-07-23 | 2013-11-20 | Открытое акционерное общество "Биосинтез" | Твердая лекарственная форма азитромицина |
CN104177457A (zh) * | 2013-05-23 | 2014-12-03 | 长春海悦药业有限公司 | 一种阿奇霉素药物原料及其制剂和用途 |
CA2939604A1 (en) * | 2013-11-11 | 2015-05-14 | Forest Laboratories Holdings Limited | Compositions and methods of treatment comprising fosfomycin disodium |
RU2649834C1 (ru) * | 2016-07-06 | 2018-04-04 | Фармалидер С.А. | Фармацевтическая композиция силденафила цитрата в форме суспензии для перорального применения |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI8110592A8 (en) * | 1981-03-06 | 1996-06-30 | Pliva Pharm & Chem Works | Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof |
US4382085A (en) * | 1982-03-01 | 1983-05-03 | Pfizer Inc. | 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents |
US4474768A (en) * | 1982-07-19 | 1984-10-02 | Pfizer Inc. | N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor |
UA27040C2 (uk) | 1987-07-09 | 2000-02-28 | Пфайзер Інк. | Кристалічhий дигідрат азитроміциhу та спосіб одержаhhя кристалічhого дигідрату азитроміциhу |
WO1989002271A1 (en) * | 1987-09-10 | 1989-03-23 | Pfizer | Azithromycin and derivatives as antiprotozoal agents |
SI9011409A (en) * | 1990-07-18 | 1995-10-31 | Pliva Pharm & Chem Works | O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them |
KR930702369A (ko) * | 1990-10-15 | 1993-09-08 | 우에노 아키라 | 에리쓰로마이신 또는 그의 유도체의 2'위치 수식 화합물 |
TW271400B (lv) | 1992-07-30 | 1996-03-01 | Pfizer | |
AU7957994A (en) | 1993-10-01 | 1995-05-01 | Procter & Gamble Company, The | Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use |
RO114740B1 (ro) | 1994-05-06 | 1999-07-30 | Pfizer | Compozitie cu eliberare controlata, procedeu de obtinere a acesteia si metoda de tratament |
-
1994
- 1994-04-29 US US08/235,069 patent/US5605889A/en not_active Ceased
- 1994-10-18 TW TW083109662A patent/TW499311B/zh not_active IP Right Cessation
-
1995
- 1995-03-15 UY UY23935A patent/UY23935A1/es not_active IP Right Cessation
- 1995-04-06 AP APAP/P/1995/000728A patent/AP566A/en active
- 1995-04-20 AT AT95302628T patent/ATE183395T1/de not_active IP Right Cessation
- 1995-04-20 ES ES95302628T patent/ES2136247T3/es not_active Expired - Lifetime
- 1995-04-20 SI SI9530303T patent/SI0679400T1/xx not_active IP Right Cessation
- 1995-04-20 DK DK95302628T patent/DK0679400T3/da active
- 1995-04-20 UA UA95048352A patent/UA34464C2/uk unknown
- 1995-04-20 EP EP95302628A patent/EP0679400B1/en not_active Expired - Lifetime
- 1995-04-20 JP JP7117628A patent/JPH07300420A/ja active Pending
- 1995-04-20 IL IL11343795A patent/IL113437A/en active IP Right Grant
- 1995-04-20 DE DE69511451T patent/DE69511451T2/de not_active Expired - Fee Related
- 1995-04-25 CN CN95104770A patent/CN1088362C/zh not_active Expired - Fee Related
- 1995-04-26 DZ DZ950046A patent/DZ1877A1/fr active
- 1995-04-26 MA MA23865A patent/MA23533A1/fr unknown
- 1995-04-26 TN TNTNSN95046A patent/TNSN95046A1/fr unknown
- 1995-04-27 CA CA002148071A patent/CA2148071C/en not_active Expired - Lifetime
- 1995-04-27 HU HU9501206A patent/HUT75244A/hu unknown
- 1995-04-28 AU AU17711/95A patent/AU709328B2/en not_active Ceased
- 1995-04-28 LV LVP-95-115A patent/LV10918B/en unknown
- 1995-04-28 CO CO95017782A patent/CO4560547A1/es unknown
- 1995-04-28 NZ NZ548384A patent/NZ548384A/en not_active IP Right Cessation
- 1995-04-28 FI FI952060A patent/FI952060A/fi not_active Application Discontinuation
- 1995-04-28 ZA ZA953439A patent/ZA953439B/xx unknown
- 1995-04-28 RU RU95106639A patent/RU2128998C1/ru not_active IP Right Cessation
- 1995-04-28 NO NO19951630A patent/NO314386B1/no unknown
- 1995-04-28 OA OA60654A patent/OA10151A/en unknown
- 1995-04-28 KR KR1019950010253A patent/KR100354310B1/ko not_active IP Right Cessation
- 1995-04-28 YU YU27195A patent/YU49483B/sh unknown
-
1999
- 1999-09-22 GR GR990402388T patent/GR3031290T3/el unknown
-
2004
- 2004-04-23 JP JP2004128641A patent/JP2005015466A/ja active Pending
-
2005
- 2005-01-20 US US11/041,194 patent/USRE39149E1/en not_active Expired - Lifetime
-
2008
- 2008-05-28 JP JP2008139689A patent/JP2008231120A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5605889A (en) | Method of administering azithromycin | |
US5621005A (en) | Aqueous pharmaceutical suspension for substantially water insoluble pharmaceutical actives | |
KR100493836B1 (ko) | 옥스카르바제핀을 포함하는 제약 조성물 | |
US8529952B2 (en) | Pharmaceutical composition containing fenofibrate and method for the preparation thereof | |
KR960011772B1 (ko) | 개선된 디데옥시 퓨린 뉴클레오사이드 경구 투여 제제 | |
CZ332598A3 (cs) | Pevná dávková forma cisapridu | |
WO2015200842A1 (en) | Composition comprising metformin and a microbiome modulator | |
KR20190019061A (ko) | 지연된 방출 경구 탐술로신 하이드로클로라이드 | |
JP2511577B2 (ja) | アルギン酸プロピレングリコ―ルエステルからなる徐放性製剤 | |
AU744318B2 (en) | Method of administering azithromycin | |
Jonkman | Food interactions with once-a-day theophylline preparations: a review | |
KR20000050265A (ko) | 아지스로마이신 경구 투여 제형을 포함하는 치료용 패키지 | |
EP0835654A1 (en) | Glucomannan-containing orally administered pharmaceutical preparations with sustained effect | |
EA042006B1 (ru) | Композиция в качестве добавки кальция | |
CN107847496A (zh) | 含有非索非那丁的软明胶胶囊 |